HI
CLX icon

Humankind Investments’s Clorox CLX Stock Holding History

Humankind Investments’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,589
Closed -$319K – 53
2025
Q3 		$319K Buy
2,589
+354
+16% +$43.9K 0.07% 104
2025
Q2 		$268K Buy
2,235
+37
+2% +$4.94K 0.07% 120
2025
Q1 		$324K Buy
2,198
+190
+9% +$29K 0.08% 110
2024
Q4 		$326K Sell
2,008
-212
-10% -$34.7K 0.08% 108
2024
Q3 		$362K Sell
2,220
-47
-2% -$6.96K 0.13% 97
2024
Q2 		$309K Buy
+2,267
New +$315K 0.08% 106
2023
Q2 		– Sell
-5,210
Closed -$824K – 129
2023
Q1 		$824K Sell
5,210
-215
-4% -$32.2K 0.34% 44
2022
Q4 		$761K Buy
5,425
+84
+2% +$11.9K 0.33% 50
2022
Q3 		$686K Buy
5,341
+565
+12% +$81.5K 0.33% 47
2022
Q2 		$673K Buy
4,776
+1,325
+38% +$189K 0.32% 48
2022
Q1 		$480K Buy
3,451
+517
+18% +$79.2K 0.2% 67
2021
Q4 		$512K Buy
2,934
+365
+14% +$60.8K 0.64% 50
2021
Q3 		$425K Buy
2,569
+893
+53% +$154K 0.65% 51
2021
Q2 		$302K Buy
+1,676
New +$306K 0.54% 59

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Humankind Investments's CLX Position: Q4 2025 in Review

Humankind Investments sold out of Clorox (CLX) in Q4 2025, closing a stake of 2,589 shares — an estimated $319K sold.

Humankind Investments first reported a position in CLX in Q2 2021 and held it in 14 quarters. The position peaked at $824K in Q1 2023. 1,049 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

  • Humankind Investments reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
  • Humankind Investments sold 2,589 Clorox shares in Q4 2025, an estimated $319K.
  • Humankind Investments first reported a position in Clorox in Q2 2021 and held it in 14 quarters.
  • Humankind Investments's Clorox position peaked at $824K in Q1 2023.
  • 1,049 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.